158 related articles for article (PubMed ID: 38242721)
1. Impact of
Yu B; Peppelenbosch M; Fuhler G
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38242721
[No Abstract] [Full Text] [Related]
2. Impact of
Magahis PT; Maron SB; Cowzer D; King S; Schattner M; Janjigian Y; Faleck D; Laszkowska M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899129
[TBL] [Abstract][Full Text] [Related]
3. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection as a potential favorable factor for immune checkpoint inhibitor therapy for gastric cancer.
Zhang MJ; Chen DS; Li S; Chen L; Qi YX; Zhang CJ
Invest New Drugs; 2021 Oct; 39(5):1436-1438. PubMed ID: 33913072
[TBL] [Abstract][Full Text] [Related]
5. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention.
Shi Y; Zheng H; Wang M; Ding S
Helicobacter; 2022 Apr; 27(2):e12878. PubMed ID: 35112435
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Noori M; Fayyaz F; Rezaei N
Immunotherapy; 2023 Jun; 15(9):657-667. PubMed ID: 37140002
[TBL] [Abstract][Full Text] [Related]
7. Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy.
Hirasaki S; Matsubara M; Ikeda F; Taniguchi H; Suzuki S
Intern Med; 2007; 46(12):855-8. PubMed ID: 17575378
[TBL] [Abstract][Full Text] [Related]
8. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
Cheung DY
Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
[No Abstract] [Full Text] [Related]
10. Targeting IL-1β in patients with advanced
Filaly HE; Outlioua A; Medyouf H; Guessous F; Akarid K
Future Microbiol; 2022 May; 17():633-641. PubMed ID: 35322705
[No Abstract] [Full Text] [Related]
11. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication.
Rugge M
Gastroenterol Clin North Am; 2015 Sep; 44(3):609-24. PubMed ID: 26314671
[TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori on immunotherapy is gaining more attention.
Shi Y; Zheng H; Guo Z; Deng R; Yu W; Song Y; Ding S
Helicobacter; 2022 Oct; 27(5):e12925. PubMed ID: 36036113
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
15. Diffuse submucosal cysts of the stomach associated with gastric cancer: contribution of Helicobacter pylori infections.
Nakao A; Sato S; Nabeyama A; Sakagami K; Isozaki H; Tanaka N
Anticancer Res; 2001; 21(5):3711-5. PubMed ID: 11848549
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Cancer Immunotherapies Is Compromised by
Oster P; Vaillant L; McMillan B; Velin D
Front Immunol; 2022; 13():899161. PubMed ID: 35677057
[No Abstract] [Full Text] [Related]
17. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.
Shimizu T; Marusawa H; Watanabe N; Chiba T
Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672
[TBL] [Abstract][Full Text] [Related]
18. [Programs for continuing medical education: a session; 2. Helicobacter pylori infection and gastric cancer].
Azuma T
Nihon Naika Gakkai Zasshi; 2013 Mar; 102(3):600-6. PubMed ID: 23777144
[No Abstract] [Full Text] [Related]
19.
Oster P; Vaillant L; Riva E; McMillan B; Begka C; Truntzer C; Richard C; Leblond MM; Messaoudene M; Machremi E; Limagne E; Ghiringhelli F; Routy B; Verdeil G; Velin D
Gut; 2022 Mar; 71(3):457-466. PubMed ID: 34253574
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated gastric carcinomas developed after successful eradication of Helicobacter pylori.
Nishikawa J; Shuto T; Yanagi A; Takagi T; Ogawa R; Sasaki S; Goto A; Hamabe K; Hashimoto S; Okamoto T; Sakaida I
Clin J Gastroenterol; 2020 Aug; 13(4):506-511. PubMed ID: 31970662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
